For instance, systemic sclerosis (SSc) patients show a higher prevalence of CHIP (25%) compared to healthy individuals (4%), with DNMT3A mutations being most common, although no significant clinical differences were noted between CHIP and non-CHIP carriers [51]. This evidence concerns the gene DNMT3A and systemic sclerosis.